Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Squamous Cell Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06996249
What this trial is testing

Prospective Data Collection Initiative on Thoracic Malignancies

Who this might be right for
Lung CancerThoracic CancerLung Cancer, Nonsmall Cell+5 more
Dutch Society of Physicians for Pulmonology and Tuberculosis 12,000
Testing effectiveness (Phase 2)Ended earlyNCT00323076
What this trial is testing

[18]F-FAZA PET Imaging Study in Patients With Cancer of the Head & Neck, Lung, Renal Cell, Brain, Lymphoma and Neuroendocrine Tumours

Who this might be right for
Renal Cell CarcinomaNeuroendocrine Tumours
AHS Cancer Control Alberta 92
Early research (Phase 1)WithdrawnNCT01637376
What this trial is testing

Photodynamic Therapy (PDT) With Temoporfin for Non-Resectable Non-Small-Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell-Lung
University of Arkansas
Testing effectiveness (Phase 2)Study completedNCT01414426
What this trial is testing

Vandetanib in Preventing Head and Neck Cancer in Patients With Precancerous Head and Neck Lesions

Who this might be right for
Lip and Oral Cavity Squamous Cell CarcinomaOral Cavity Verrucous CarcinomaPrecancerous Condition
University of Chicago 20
Very early researchEnded earlyNCT03454243
What this trial is testing

Oral Immunomodulatory Tyrosine Kinase Inhibitor in Patients With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced or Metastatic Solid Tumors
Hoffmann-La Roche 1
Testing effectiveness (Phase 2)Study completedNCT00033618
What this trial is testing

Ixabepilone in Treating Patients With Metastatic or Recurrent Squamous Cell Cancer of the Head and Neck

Who this might be right for
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Metastatic Squamous Neck Cancer With Occult PrimaryRecurrent Salivary Gland Cancer+31 more
National Cancer Institute (NCI) 144
Early research (Phase 1)Ended earlyNCT04795713
What this trial is testing

Study of MT-6402 in Subjects With Advanced Solid Cancer That Expresses PD-L1

Who this might be right for
Advanced Solid TumorNon-small Cell Lung CancerSquamous Cell Carcinoma of Head and Neck
Molecular Templates, Inc. 64
Not applicableEnded earlyNCT03053960
What this trial is testing

Helical CT, PET/CT, MRI, and CBCT Alone or in Combination in Predicting Jaw Invasion in Patients With Oral Cancer

Who this might be right for
Oral Cavity Squamous Cell Carcinoma
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 8
Large-scale testing (Phase 3)Study completedNCT00002623
What this trial is testing

Chemotherapy Followed by Surgery or Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
European Organisation for Research and Treatment of Cancer - EORTC 640
Large-scale testing (Phase 3)Study completedNCT01233843
What this trial is testing

Chemoradiotherapy HNSCC, Randomized Study, Docetaxel,Cisplatin, 5FU,Erbitux.

Who this might be right for
Squamous Cell Head and Neck Carcinoma
Groupe Oncologie Radiotherapie Tete et Cou 370
Testing effectiveness (Phase 2)Study completedNCT00055835
What this trial is testing

S0121, Neoadjuvant Carboplatin, Paclitaxel, and Gemcitabine Followed by Cisplatin and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Carcinoma of the Urothelium

Who this might be right for
Bladder CancerUrethral Cancer
SWOG Cancer Research Network 7
Large-scale testing (Phase 3)Study completedNCT05802290
What this trial is testing

NIVolumab in Subjects With Recurrent or Metastatic Platinum-refrACTORy SCCHN

Who this might be right for
Squamous Cell Carcinoma of Head and Neck
Gruppo Oncologico del Nord-Ovest 124
Not applicableStudy completedNCT04764643
What this trial is testing

The Efficacy of N-acetylcysteine on Alleviating Symptom Caused by Lugol Chromoendoscopy

Who this might be right for
Esophageal Squamous Cell Carcinoma
Xijing Hospital of Digestive Diseases 140
Not applicableStudy completedNCT03830710
What this trial is testing

8-Hydroxy-2-Deoxyguanosine ,Total Antioxidant Capacity in Oral Premalignant and Malignant Lesions

Who this might be right for
Premalignant Lesion
Fayoum University 120
Testing effectiveness (Phase 2)Looking for participantsNCT05419089
What this trial is testing

The Sinai Robotic Surgery Trial in HPV-related Oropharyngeal Squamous Cell Carcinoma (SIRS 2.0 Trial)

Who this might be right for
HPV-positive Oropharyngeal Squamous Cell Carcinoma
Icahn School of Medicine at Mount Sinai 83
Not applicableStudy completedNCT01466244
What this trial is testing

Biomarkers in Patients With Metastatic or Recurrent Head and Neck Cancer Treated With Cisplatin and Cetuximab on ECOG-E5397

Who this might be right for
Head and Neck Cancer
Eastern Cooperative Oncology Group 42
Testing effectiveness (Phase 2)UnknownNCT01660399
What this trial is testing

Clinical Trial of Boanmycin Hydrochloride With Docetaxel for Patients With Lung Squamous Cell Cancer as Chemotherapy

Who this might be right for
Squamous Cell Lung Cancer
Tianjin Medical University Cancer Institute and Hospital 300
Testing effectiveness (Phase 2)Study completedNCT00815308
What this trial is testing

Erbitux Combined With Chemo-radiotherapy in Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Cancer
Shandong Cancer Hospital and Institute 55
Testing effectiveness (Phase 2)Ended earlyNCT03827850
What this trial is testing

FGFR Inhibitor in FGFR Dysregulated Cancer

Who this might be right for
Lung CancerNSCLCPulmonary Neoplasm+2 more
Lung Cancer Group Cologne 22
Large-scale testing (Phase 3)Study completedNCT02766335
What this trial is testing

Lung-MAP: Durvalumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers

Who this might be right for
Recurrent Squamous Cell Lung CarcinomaStage IV Squamous Cell Lung Carcinoma AJCC v7
SWOG Cancer Research Network 116
Next Page